REVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b), 0.1%, packaged in 29.6 mL (1.0 FL OZ) bottles (NDC 63347-120-02) and 88.7 mL (3.0 FL OZ) tubes (NDC 63347-120-01), Blaine Labs Inc., Santa Fe Springs, CA 90670
Published March 30, 2022 · Recall initiated: January 25, 2022
Summary
FDA records drug Class I recall D-0668-2022, published March 30, 2022 and initiated January 25, 2022. Recalling firm: Blaine Labs Inc; Status: Terminated; Reported quantity: 1119 (1 oz.) bottles/ 772 (3 oz.) tubes; Lot: Lot/Batch #: BL 2844, Expiration date 2/19/2023. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-sterile Product; FDA analysis found the product to be contaminated with Bacillus cereus.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email if REVITADERM WOUND CARE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- REVITADERM WOUND CARE
- Manufacturer
- Blaine Labs Inc
- Distributor
- Nationwide in 17 States to 45 doctors.
- Lot
- Lot/Batch #: BL 2844, Expiration date 2/19/2023
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARevitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL)July 8, 2026
- FDABetamethasone Dipropionate Lotion USP, 0.05%* (Augmented), packaged in a) 30 mL (29 grams) bottles, NDCMarch 30, 2022
- FDAClobetasol Propionate Cream USP, 0.05%, packaged in a) 15 grams tube, NDC 52565-051-15; b) 30 grams tube, NDCMarch 30, 2022
- FDA20545 Vitale Silver calcium Alginate Dressings 4x5, 10/boxMarch 23, 2022
- FDASAM CHEST SEAL REF CS203-EN Combo LOT Y060321-09March 23, 2022
- FDALYFO DiskMarch 23, 2022
Questions about this recall
Was REVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b), 0.1%, packaged in 29.6 mL (1.0 FL OZ) bottles (NDC 63347-120-02) and 88.7 mL (3.0 FL OZ) tubes (NDC 63347-120-01), Blaine Labs Inc., Santa Fe Springs, CA 90670 recalled?
Yes. FDA published recall D-0668-2022 on March 30, 2022. Reported hazard: Microbial Contamination of Non-sterile Product; FDA analysis found the product to be contaminated with Bacillus cereus.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: REVITADERM WOUND CARE.